Login
$AURX
$1.21 +$0.10 (9.01%) Close

$AURX SEC Filings

Filed On Filing
06 Oct 2026 Form 4: Pittman Scott M., Director

Granted 4,500 Second Restated Warrant (right to buy) ($6.75K) · Granted 458 Prepayment Restated Warrant (right to buy) ($687)

06 Oct 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant +1 more

This Assignment, Joinder, and Amendment No. 1 to Amended and Restated Loan and Security Agreement (this “Amendment”) is entered into as of September 30, 2026 (the “Amendment Date”), by and among Nuo Therapeutics, Inc., a Delaware corpora...

31 Aug 2026 Form 4/A: Jorden David Emerson, Director

Bought 789 shares ($844) · Bought 7,984 shares ($8.69K)

28 Aug 2026 Form 4: Jorden David Emerson, Director

Received 789 shares as a grant or award ($844) · Received 7,984 shares as a grant or award ($8.69K)

17 Aug 2026 8-K: Results of Operations and Financial Condition
14 Aug 2026 FORM 10-Q
02 Jul 2026 Form 4: Clausen Peter, CSO/COO

Granted 65,000 Option to purchase common stock

02 Jul 2026 Form 4: Jorden David Emerson, Director

Granted 125,000 Option to purchase common stock · Received 162,500 shares by exercise or conversion ($163K) · Gave up 160,892 shares to cover exercise price or tax ($163K)

02 Jul 2026 Form 4: Pittman Scott M., Director

Granted 30,000 Option to purchase common stock · Received 40,000 shares by exercise or conversion ($40K) · Gave up 39,604 shares to cover exercise price or tax ($40K)

02 Jul 2026 Form 4: Winzer C Eric, Director

Granted 30,000 Option to purchase common stock · Received 40,000 shares by exercise or conversion ($40K) · Gave up 39,604 shares to cover exercise price or tax ($40K)

02 Jul 2026 Form 4: Mintz Paul, Director

Granted 30,000 Option to Purchase Common Stock

05 Jun 2026 Form 4: Jorden David Emerson, Director

Received 13,245 shares as a grant or award ($14.5K)

03 Jun 2026 SCHEDULE 13D/A
03 Jun 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
02 Jun 2026 Form 4: Pittman Scott M., Director

Granted 17,450 Interim Warrant (right to buy) ($26.2K) · Disposed of 36,750 Second Warrant (right to buy) (Disposition to Issuer) ($55.1K) · Disposed of 7,516 Prepayment Warrant (right to buy) (Disposition to Issuer) ($11.3K) · 2 more

02 Jun 2026 Form 4/A: Pittman Scott M., Director

Granted 30,050 Initial Warrant (right to buy) ($45.1K) · Granted 36,750 Second Warrant (right to buy) ($55.1K) · Granted 7,516 Prepayment Warrant (right to buy) ($11.3K)

14 May 2026 FORM 10-Q
14 May 2026 8-K: Results of Operations and Financial Condition
30 Mar 2026 FORM 10-K
12 Feb 2026 SCHEDULE 13G/A

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support